Effect of ultrasound-guided costotransverse foramen block on perioperative analgesia of single port thoracoscopy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045972

Enrollment

Unknown

Registered

2021-04-30

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Group 1:Costotransverse foramen block

Group 2:Thoracic paravertebral nerve block

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing single-port thoracoscopic radical resection of lung cancer; 2. There is no restriction on gender, age 1865, BMI 1928kg/m2, ASA I-III level.

Exclusion criteria

Exclusion criteria: 1. Severe heart and lung disease, severe liver and kidney disease, allergy to local anesthetics, partial puncture infection, coagulation dysfunction, history of thoracic spine surgery; 2. Uncooperative mental disorders, opioid and alcohol dependence.

Design outcomes

Primary

Measure	Time frame
Operation time of nerve block;VAS pain score at rest and coughing at 2, 6, 12, 24 and 48 hours after operation;Sufentanil dosage;	—

Countries

China

Contacts

Public ContactHuang Song

The Second Affiliated Hospital of Nanchang University

huangsongjiayou@foxmail.com+86 18970949646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026